The genetic alterations of the TJP family in bladder cancer, examined using cBioPortal, showed that the genetically altered ratios of TJP1, TJP2, and TJP3 were 3%, 3%, and 1.7%, respectively (Fig. 3A). This evidence concerns the gene TJP3 and urinary bladder cancer.